Skip to main content
. 2022 Sep 22;14(19):4606. doi: 10.3390/cancers14194606

Table 3.

Median overall survival of patients treated with 223Ra according to NLR score.

Good Intermediate Poor p-Value
MedianOS
Months (95% CI)
16.0 (14.8–25.5) 9.1 (7.1–NR) 8.7 (8.3–NR) Log rank 0.0001
HR (95% CI) Ref 3.04 (1.62–5.68) 2.88 (1.31–6.32) Cox model 0.001

Hazard Ratio (HR), Not Reached (NR), Overall Survival (OS), Reference (Ref), Neutrophil to Lymphocyte Rate (NLR) Score: Good: NLR baseline ≤ 5 Furthermore, NLR at 12 week ≤ 5, Intermediate: NLR at baseline ≤ 5 and at 12 week > 5, Poor: NLR at baseline > 5 and NLR at 12 week > 5.